Bone Health · Bone Mineral Density
Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect
Bliuc D, Tran T, Adachi JD, Atkins GJ, Berger C, van den Bergh J, Cappai R, Eisman JA, van Geel T, Geusens P, Goltzman D, Hanley DA, Josse R, Kaiser S, Kovacs CS, Langsetmo L, Prior JC, Nguyen TV, Solomon LB, Stapledon C, Center JR, CaMos Research Group
Cite this paper
Bliuc, D., Tran, T., Adachi, J. D., Atkins, G. J., Berger, C., van den Bergh, J., Cappai, R., Eisman, J. A., van Geel, T., Geusens, P., Goltzman, D., Hanley, D. A., Josse, R., Kaiser, S., Kovacs, C. S., Langsetmo, L., Prior, J. C., Nguyen, T. V., Solomon, L. B., Stapledon, C., Center, J. R., & CaMos Research Group (2022). Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect. J Bone Miner Res, 37(5), 1075-1076. https://doi.org/10.1002/jbmr.4530
Bliuc D, Tran T, Adachi JD, Atkins GJ, Berger C, van den Bergh J, Cappai R, Eisman JA, van Geel T, Geusens P, Goltzman D, Hanley DA, Josse R, Kaiser S, Kovacs CS, Langsetmo L, Prior JC, Nguyen TV, Solomon LB, Stapledon C, Center JR; CaMos Research Group. Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect. J Bone Miner Res. 2022;37(5):1075-1076. doi:10.1002/jbmr.4530
Bliuc, Dana, et al. "Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect." J Bone Miner Res, vol. 37, no. 5, 2022, pp. 1075-1076.
For EndNote, Zotero or Mendeley:
License
No open license is recorded for this paper. Reuse terms are set by the publisher.
